
Risk in scientific experimentation; bariatric surgery parameters; ‘generally recognized as safe’ (we hope) – Morning Medical Update
The top news stories in medicine today.
“Scientific inquiry is a risky business,” yet not all projects are equally risky, according to two researchers who analyzed risk avoidance or pursuit of high-risk work. Scientists, including physicians, are rewarded for advances in their fields, not necessarily for how much scientific risk they embrace. Here’s an
Glucagon-like peptide-1 agonist drugs are the new hit pharmaceuticals for physicians and patients dealing with Type-1 diabetes and obesity. Instead of drugs, bariatric surgery still remains an option for patients dealing with morbid obesity. This
The U.S. Food and Drug Administration regulates “additives” that go into the foods that physicians and patients eat. But it’s like the wild west for ingredients
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.